Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Shanghai Pharmaceuticals Holding Co Ltd (S1R.BE)

Berlin - Berlin Delayed Price. Currency in EUR
1.55000.0000 (0.00%)
At close: 08:04AM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.5500
Open1.5500
Bid1.5300 x 0
Ask1.5800 x 0
Day's Range1.5500 - 1.5500
52 Week Range1.2775 - 1.8010
Volume2,500
Avg. Volume40
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for S1R.BE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update

      Company to present clinical data for efzofitimod (ATYR1923) in pulmonary sarcoidosis at upcoming American Thoracic Society International Conference in May. Planned registrational study of efzofitimod in pulmonary sarcoidosis on track to initiate in the third quarter of 2022. FDA granted orphan drug designation for efzofitimod for the treatment of systemic sclerosis; company to explore potential expansion of clinical program in other ILD. Ended the first quarter 2022 with $98.7 million in cash, c

    • ACCESSWIRE

      Love Hemp Group PLC Announces Update Regarding Trading Suspension

      LONDON, UK / ACCESSWIRE / May 9, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, wishes to provide an update on the temporary suspension of the trading in shares of Love Hemp.As previously announced, the reason for the suspension is that Peterhouse Capital Limited ("Peterhouse") has resigned as the AQSE Corporate Advisor and the Company needs to appoint a new AQSE Corporate Advisor in order that trading can

    Advertisement
    Advertisement